Validation of Bacopa monnieri as a nootropic drug: analysis of the existing preclinical and clinical data

Authors

  • Rakesh Kumar Department of Botany, W.R.S. Govt. College Dehri, District Kangra-176022, H.P. India
  • Nancy Gupta Department of Biochemistry, Faculty of Science, University of Allahabad, Prayagraj-211002, UP, India,
  • Ujla Minhas Department of Biochemistry, Faculty of Science, University of Allahabad, Prayagraj-211002, UP, India,

Keywords:

Nootropic drugs, Bacopa monnieri, preclinical, clinical studies, clinical trials.

Abstract

Nootropics or smart drugs are compounds used as cognitive enhancers; known for their neuroprotective role. Bacopa monnieri was first chronicled in several ancient Ayurvedic texts. Scientific validation of ayurvedic herbs is important for their recognition and acceptance as standard drug. Several preclinical studies and few clinical studies have been conducted to validate the role of Bacopa monnieri as a nootropic drug. This review analyses the preclinical and clinical studies in order to validate its use as a drug for improving memory and learning. Furthermore, this review also tries to understand the mechanisms involved in enhancement of memory and learning

Published

2022-06-30

How to Cite

Kumar, R., Gupta, N., & Minhas, U. (2022). Validation of Bacopa monnieri as a nootropic drug: analysis of the existing preclinical and clinical data. The Journal of the Indian Botanical Society, 102(03), 229–237. Retrieved from https://jibs.mripub.com/index.php/JIBS/article/view/39

Issue

Vol. 102 No. 03 (2022): Journal of Indian Botanical Society

Section

Articles